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Abstract
Introduction
Use of complementary and alternative medicine (CAM)
for chronic conditions has increased in recent years. There
is little information, however, on CAM use among adults
with clinic-confirmed diagnoses, including arthritis, who
are treated by primary care physicians.
Methods
To assess the frequency and types of CAM therapy used
by Hispanic and non-Hispanic white women and men with
osteoarthritis, rheumatoid arthritis, or fibromyalgia, we
used stratified random selection to identify 612 partici-
pants aged 18–84 years and seen in university-based pri-
mary care clinics. Respondents completed an interviewer-
administered survey in English or Spanish. 
Results
Nearly half (44.6%) of the study population was of
Hispanic ethnicity, 71.4% were women, and 65.0% had
annual incomes of less than $25,000. Most (90.2%) had
ever used CAM for arthritis, and 69.2% were using CAM
at the time of the interview. Current use was highest for
oral supplements (mainly glucosamine and chondroitin)
(34.1%), mind-body therapies (29.0%), and herbal topical
ointments (25.1%). Fewer participants made current use
of vitamins and minerals (16.6%), herbs taken orally
(13.6%), a CAM therapist (12.7%), CAM movement ther-
apies (10.6%), special diets (10.1%), or copper jewelry or
magnets (9.2%). Those with fibromyalgia currently used
an average of 3.9 CAM therapies versus 2.4 for those
with rheumatoid arthritis and 2.1 for those with
osteoarthritis. Current CAM use was significantly asso-
ciated with being female, being under 55 years of age,
and having some college education.
Conclusion
Hispanic and non-Hispanic white arthritis patients used
CAM to supplement conventional treatments. Health care
providers should be aware of the high use of CAM and
incorporate questions about its use into routine assess-
ments and treatment planning. 
Introduction
Rheumatic conditions such as arthritis and chronic
joint pain are the leading cause of limitation in daily
activities and disability among adults in the United
States (1). In 2001, self-reported data obtained by the
U.S. Behavioral Risk Factor Surveillance System indi-
cated that a third of American adults had chronic joint
symptoms or physician-diagnosed arthritis (1).
Researchers estimate that by 2030, some 41 million
adults aged 65 and older will have arthritis or chronic
joint symptoms (2). Management of chronic rheumatic
conditions usually consists of physician-prescribed med-
ications, physician-recommended over-the-counter med-
ications, physical therapy, and self-management strate-
gies recommended by physicians and the American
College of Rheumatology (3) such as exercise, weight con-
trol, use of heat or cold, intermittent rest, and stress
management. Increasingly, adults are also adopting com-
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plementary and alternative medicine (CAM) to help
manage their chronic conditions (4,5).
This study addresses three gaps in the literature on
CAM use for arthritis. First, CAM use among adults with
physician-confirmed arthritis who are treated by primary
care physicians has not been well studied. Previous stud-
ies on prevalence of CAM use for arthritis in the United
States have typically included either patients seen by
rheumatologists (6-8) or community-based samples of
adults with self-reported arthritis (9-12). The rheumatol-
ogy clinic studies have used clinic-confirmed diagnoses but
excluded adults treated by primary care physicians and
have had small samples (n = 135–232). The community-
based surveys have included adults treated by any type of
physician or none at all and have had larger samples (n =
122–1424), but these studies have relied on self-report to
determine the presence of arthritis. Many such partici-
pants did not know what type of arthritis they had (9,10). 
A second gap in the literature is the underrepresenta-
tion of Hispanic adults in arthritis-specific CAM-use stud-
ies in the United States. Two community-based studies
conducted 10 or more years ago found that Hispanic and
African American adults with arthritis were more likely
to use prayer, take herbs orally, or use ointments and
were less likely to see a physician for arthritis than were
non-Hispanic whites (13,14). Hispanic adults are better
represented in studies of CAM use among the general
population (4). In studies of CAM use for any purpose
among adults in the general population, Hispanics or
Latinos have been as likely as non-Hispanic whites to use
self-care types of CAM but less likely to have seen a CAM
provider (4,5,15-19).
A third shortcoming is that there seems to be little infor-
mation describing use of specific CAM therapies by type of
arthritis, even though the three most common types of
arthritis — osteoarthritis, rheumatoid arthritis, and
fibromyalgia — differ greatly in disease processes, clinical
presentations, persons affected, and the CAM therapies
shown to be effective (20,21). Osteoarthritis affects both
women and men primarily over age 45, whereas rheuma-
toid arthritis and fibromyalgia can start at younger ages
and affect more women than men (20). 
The purpose of this study is to assess the frequency and
types of CAM therapy used by Hispanic and non-
Hispanic white adults treated by primary care physicians
in university-affiliated clinics in Albuquerque, NM, as
part of the management of osteoarthritis, rheumatoid
arthritis, or fibromyalgia.
Methods 
Recruitment
Hispanic and non-Hispanic white women and men aged
18–84 years seen in any of six primary care clinics at the
University of New Mexico in Albuquerque between June
2000 and May 2001 with a diagnostic code for osteoarthri-
tis, rheumatoid arthritis, or fibromyalgia were eligible for
inclusion in the sample. The sampling method is dis-
cussed below (Statistical analysis). Of the 1684 sampled
patients, 22 (1.3%) had died. For 97 (5.8%), permission to
contact was denied by the primary care physician, and for
69 (4.1%), no responding physician could be found.
Introductory letters were sent to the 1496 patients
(88.8%) for whom physician consent was obtained.
Trained bilingual interviewers made telephone calls in
English or Spanish to these patients to invite them to par-
ticipate in the study. Because of the known inaccuracy of
ethnicity coding in the clinics, interviewers screened
patients during the invitational calls to ensure they self-
identified as Hispanic or non-Hispanic white and spoke
English or Spanish. During recruitment, we learned that
the diagnostic code (ICD-9-CM) for fibromyalgia was not
specific to fibromyalgia, but also included people with
other muscular conditions. Consequently, some patients
denied having fibromyalgia or arthritis when contacted
and were excluded.
Interviews
In-person interviews were conducted by appointment
in participants’ homes or in a clinic, according to partici-
pant preference. The interviewers were university staff
trained to conduct interviews for a variety of epidemio-
logical studies.
We used validated and reliable measures from the
Centers for Disease Control and Prevention’s Behavioral
Risk Factor Surveillance System for demographic ques-
tions, perceived health status, and comorbidity (22). The
20-item Stanford Health Assessment Questionnaire
(HAQ), commonly used in arthritis research, was the
measure of functional ability (23). The five-item short form
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and Callahan (24), measured perceived helplessness (25).
Fiscella’s four-item Medical Skepticism scale (26)
assessed beliefs about desire to control one’s own health
care. We used the Faces Pain Scale to assess average pain
over the past week, with a range from 0 = no pain to 10 =
worst possible pain (27,28). We used a visual analog scale
to evaluate average fatigue over the past week, with a
range from 0 = no fatigue to 10 = extreme fatigue (29). A
four-item scale measured sleep problems in the past
month (30). We also included Marin’s five-item Hispanic
acculturation scale (31).
We selected CAM items based on a review of the litera-
ture and feedback from 39 volunteers in four focus groups.
CAM items were included in the survey if they were
reported in the CAM literature as commonly used for
osteoarthritis, rheumatoid arthritis, or fibromyalgia, or if
focus group participants said they were locally used for
arthritis. (The Appendix provides a full list of CAM thera-
pies included in the survey.) Participants were also asked
to describe other therapies they were using. Current use
was defined as use at the time of the interview.
Pilot testing of the questionnaire was conducted in two
waves. The first wave involved adults who had arthritis or
fibromyalgia and were known to the researchers. In the
second wave, interviewers conducted pilot interviews
using the modified survey with 18 volunteers recruited
from the community who met eligibility criteria for the
study. Final revisions were then made to the English-lan-
guage questionnaire. Previously validated Spanish trans-
lations were used for the functional ability HAQ (32);
demographic, health status, and comorbidity items (22);
Arthritis Helplessness Index (33); and acculturation scale
(31). A native Spanish speaker born in Mexico who works
in health care in New Mexico translated the remaining
measures. Several Spanish-speaking researchers
reviewed the translations to ensure a match to the
English meaning, proper grammar, and correct spelling
and then pilot tested the Spanish version with Spanish
speakers who had arthritis. 
Statistical analysis
Participants were randomly selected from the clinic
population within strata defined by ethnicity, sex, and
diagnostic group. To obtain more rheumatoid arthritis
participants, more Hispanics, and more men, we sam-
pled patients in these categories at higher rates than
non-Hispanic white women with diagnoses of
osteoarthritis or fibromyalgia. The strata were based on
the clinic-assigned ethnicity and diagnostic group,
although self-reported ethnicity and self-reported diag-
nosis of fibromyalgia were used in the analysis.
Sampling fractions were computed as the ratio of the
number of participants who completed an interview to
the total number of clinic patients within each stratum.
The inverses of the sampling fractions were used as
weights in all analyses. SUDAAN software release 8.0.2
(Research Triangle Institute, Research Triangle Park,
NC) was used to compute all weighted estimates of pro-
portions and tests of significance by means of a stratified
sampling with replacement design (34). 
We conducted analyses separately by diagnostic
group because the three types of rheumatological condi-
tions are different disease processes with different clin-
ical presentations and patient demographics. For
arthritis type, we coded each participant as having pri-
marily rheumatoid arthritis, fibromyalgia, or
osteoarthritis. The clinic diagnostic codes were used to
identify respondents as having rheumatoid arthritis or
osteoarthritis. Because of inaccuracies in the diagnostic
coding for fibromyalgia, we used participants’ self-
reports to code that condition. Participants having more
than one type of arthritis were classified in the follow-
ing order of priority: 1) rheumatoid arthritis, 2)
fibromyalgia, and 3) osteoarthritis. Ninety-five patients
were classified as having rheumatoid arthritis, 95 as
having fibromyalgia, and 422 as having osteoarthritis.
One patient with rheumatoid arthritis also had a clini-
cal diagnosis of osteoarthritis, and six reported having
fibromyalgia. Nineteen with self-reported fibromyalgia
also had a clinical diagnosis of osteoarthritis. Subjects
who reported both Hispanic and non-Hispanic ethnicity
were coded as Hispanic. 
Several survey items were excluded from frequency
counts and analyses of CAM use. Multiple vitamins,
prayer, and drawing upon religious beliefs were exclud-
ed because participants had difficulty distinguishing
between use for general health and use specifically for
arthritis. Calcium, vitamin D, and folic acid were exclud-
ed because participants reported that their physicians
had recommended their use for other health reasons.
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Results
Demographics
A total of 612 primary care clinic patients completed the
surveys. Of the 1496 primary clinic patients sent intro-
ductory letters, 286 (19.1%) were ineligible per the tele-
phone screening (self-reported ethnicity other than
Hispanic or non-Hispanic white or denied having arthri-
tis). Of the 1210 eligible patients, 110 (9.1%) were too ill to
participate because of other illnesses, 36 (3.0%) had moved
out of the area, 302 (25.0%) refused, 96 (7.9%) had no cur-
rent contact information, and 54 (4.5%) with valid tele-
phone numbers could not be reached despite repeated calls
at different times of the day. The final response rate of
completed interviews among eligible patients was 50.6%
(612 of the 1210 eligible patients). Information was not
available on nonrespondents to compare their characteris-
tics with those of respondents.
Weighted estimates of the proportions of the clinic pop-
ulation with each of several characteristics, both overall
and by diagnostic group, are shown in Table 1. An esti-
mated 44.6% were of Hispanic ethnicity and 71.4% were
female. About one fourth (26.9%) were aged younger than
55 years, 35.4% were aged 55–64, and 37.7% were aged
65–84. Of the Hispanics, 71.4% self-identified as Spanish
American, 20.3% as Mexican American or Mexican, 2.9%
as Central or Latin American, and 2.0% as “other” (3.4%
were unidentifiable either because the respondents did not
know or refused to answer) (data not shown). As expected,
clinic patients with rheumatoid arthritis and fibromyalgia
were younger and included a higher proportion of women
and non-Hispanic whites, and they had more education
than the group with osteoarthritis. Patients with
fibromyalgia had higher levels of pain in the past week
and more frequent physician visits for their rheumatolog-
ic condition than did patients with rheumatoid arthritis or
osteoarthritis (P < 0.01).
Overall CAM use
Most of the clinic population (90.2%) had ever tried CAM
therapies for their arthritis, and 69.2% currently used one
or more CAM therapies at the time of the interview (Table
2). CAM users with fibromyalgia had ever tried an average
of 5.5 CAM therapies versus 4.4 among those with
rheumatoid arthritis and 3.1 among those with
osteoarthritis (P < .05) (data not shown). CAM users with
fibromyalgia currently used an average of 3.9 CAM thera-
pies compared with 2.4 among those with rheumatoid
arthritis and 2.1 among those with osteoarthritis (P < .05)
(data not shown).
Types of therapies used
Fibromyalgia patients were most likely to use each type
of CAM compared to those with rheumatoid arthritis or
osteoarthritis (Table 2). Specific CAM therapies currently
used by at least 3% of the clinic population in at least one
of the diagnostic groups are shown in Table 3. Patients
with osteoarthritis most commonly used the nutritional
supplements glucosamine (25.2%) and chondroitin (17.9%)
and the mind-body therapies of meditation (10.1%) and
relaxation techniques (10.0%) to manage their arthritis.
Rheumatoid arthritis patients most commonly used relax-
ation (16.3%), glucosamine (15.8%), meditation (11.1%),
and vitamin C (10.0%). Only 6.1% of rheumatoid arthritis
patients currently used fish oil supplements, and only
1.3% used supplements containing gamma linolenic acid
(GLA) (borage oil, evening primrose oil, and black currant
oil). Fibromyalgia patients most commonly used breathing
techniques (36.7%), relaxation (28.9%), meditation
(27.6%), music therapy (22.8%), glucosamine (20.7%), visu-
alization (19.6%), acupressure (19.5%), massage therapy
(17.1%), magnesium (14.1%), and yoga (13.2%).
Fibromyalgia patients with a concurrent clinical diagnosis
of osteoarthritis were more likely to use glucosamine than
were those without osteoarthritis (glucosamine: 49.3% vs
13.8%, P = .01; chondroitin: 25.6% vs 6.9%, P = .08) (data
not shown). 
Patients currently used more than 40 different herbs
taken orally and more than 30 topical herbal therapies for
arthritis. As Table 3 shows, massage therapists, chiroprac-
tors, and acupuncturists were the most commonly seen
CAM therapists. Within the items worn category, only mag-
nets and copper bracelets were currently used by more than
1% of patients. Respondents were asked about several CAM
movement therapies, and they most often named yoga, tai
chi, or the Feldenkrais method of movement reeducation.
Current use of special diets included an “arthritis diet” high
in fish and fresh fruits and vegetables and low in potatoes,
tomatoes, eggplant, and peppers. Patients also used several
other special diets. Energy therapies included acupressure,
reiki, reflexology, therapeutic touch, aromatherapy, and
other therapies intended to affect theorized energy fields
within and surrounding the body. 
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Among osteoarthritis and fibromyalgia patients, current
use of any type of CAM did not differ by demographic char-
acteristics (Table 4). Among rheumatoid arthritis partici-
pants, however, current CAM use was associated with dis-
ease duration of 0–5 years and having some college educa-
tion (P < 0.05). Tests for interactions showed the associa-
tion between ethnicity and current use of any type of CAM
differed by diagnostic group. Similar proportions of
Hispanic and non-Hispanic white osteoarthritis patients
currently used any type of CAM, whereas significantly
more non-Hispanic whites with rheumatoid arthritis cur-
rently used CAM than did Hispanics with rheumatoid
arthritis. We tested other measures of disease burden not
shown in Table 4 (including functional ability, fatigue,
sleep problems, perceived general health status, and pres-
ence of comorbidity) for possible associations with current
CAM use, but we found none that was significant. Overall,
current use of any type of CAM was significantly higher
among women (P = .03), patients under age 55 (P = .02),
and those with some college education (P = .003).
Other aspects of CAM use
Additional results not presented in the tables are
described below. The percentages of the clinic population
that found CAM therapies somewhat helpful or helped a
lot, among those who had ever used that type of CAM, are
as follows: mind-body therapies (90.4%); CAM movement
therapies (82.7%); CAM therapists (79.8%); energy thera-
pies (79.4%); herbal topical rubs (77.1%); special diets
(64.9%); vitamins and minerals (63.0%); herbs taken oral-
ly (61.5%); nutritional supplements (57.0%); homeopathic
remedies (49.6%); and items worn (36.9%). Gaps between
percentages of ever use and current use were greatest for
those CAM therapies that fewer patients found useful,
such as wearing copper jewelry or magnets, or for costly
therapies, such as seeing CAM therapists or using glu-
cosamine and chondroitin. Among those who had ever
used CAM, 13.6% of osteoarthritis patients, 17.3% of those
with rheumatoid arthritis, and 30.6% of those with
fibromyalgia reported that CAM use changed their use of
conventional therapies. The most common change report-
ed in open-ended responses was the use of smaller
amounts or doses of prescription or over-the-counter med-
ication (52.8%). Of those who had ever tried CAM, 6.6%
used only CAM therapies and no conventional treatments.
Overall, 22.6% of those who had ever used CAM had never
mentioned their CAM use to their medical doctor, 66.6%
had told their doctor, 8.0% said their doctor had suggested
the therapies, and 2.7% were unsure. More CAM users
with fibromyalgia (82.8%) told their doctor about their
CAM use than did those with rheumatoid arthritis (69.7%)
or osteoarthritis (62.0%) (P < .001). 
Open-ended responses on reasons for using CAM were in
the same rank order by how often they were mentioned in
each diagnostic group. Overall, reasons mentioned includ-
ed the following: to relieve pain (36.1%); to prevent disease
progression (14.3%); to feel better (13.7%); to try CAM to
see if it would help (13.5%); and because CAM therapies
had helped them (9.2%). Sources of information about
CAM were also similar across the diagnostic groups.
Overall, these sources included family or friends (66.1%),
medical doctors (56.1%), magazines or books (34.6%), and
radio or television or newspapers (22.6%); only 11.3%
named the Internet as a source. Patients who had ever
used any type of CAM currently spent from $0 to more
than $500 per month on CAM therapies, with 67.7%
spending $50 or less per month and 15.1% spending more
than $100 per month. Thirty percent of CAM users with
fibromyalgia spent more than $100 per month on CAM
versus 24.0% of those with rheumatoid arthritis and 9.7%
of those with osteoarthritis.
Discussion 
In this study, 90.2% of Hispanic and non-Hispanic white
arthritis patients treated by primary care physicians had
ever tried CAM for their arthritis, and 69.2% currently
used one or more CAM therapies. Overall, 17.2% changed
their use of conventional treatments after starting to use
CAM, and more than one fifth (22.6%) had never discussed
their CAM use with their medical doctor. These findings
are important because they indicate that conventional
therapies alone are not meeting the needs of arthritis
patients. Furthermore, many patients are supplementing
or decreasing their medical treatment with or without their
physician’s knowledge. Because some CAM therapies may
interact with conventional medications and treatments, it
is important for health care providers to be aware that
many arthritis patients are using therapies on their own
and to inquire specifically about their patients’ CAM use.
The prevalence of CAM use found in this study is high-
er than the range of 33%–66% reported in previous arthri-
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tis studies (6-12). Differing definitions of CAM may partly
explain the disparity, as the present study included a
broader array of mind-body therapies, energy therapies,
and CAM movement therapies than most previous stud-
ies. Geographic location may also partly explain the differ-
ence, given that national studies of CAM use among the
general population have found higher use in the West than
in other regions of the United States (5,18). Also, some
arthritis studies have included only older adults (9-12)
who in previous studies were less likely to use CAM than
adults under age 55 (4,5). 
As in previous studies, most CAM use in the present
study was self-care, with a smaller percentage of people
seeing a CAM therapist (4-6,10,12,15). Consistent with
some previous studies, current use of any type of CAM in
this study was associated with being female, being
under age 55, and having some college education, and
use did not differ by Hispanic ethnicity (4-6,16,19).
National studies on CAM use among the general popu-
lation found higher income was associated with CAM
use (4,5), but the present study and some other arthritis
CAM studies found no association between CAM use and
income (6,9,11).
The finding that patients with osteoarthritis used a
lower average number of CAM therapies than those with
fibromyalgia and rheumatoid arthritis conflicts with a
previous rheumatology clinic study in which patients
with rheumatoid arthritis were less likely to use CAM
than patients with osteoarthritis or fibromyalgia (6).
Both that study and ours, however, had small numbers of
patients with fibromyalgia and rheumatoid arthritis, and
the previous study had very few patients with
osteoarthritis. Thus, caution should be used in interpret-
ing this finding. In previous studies among adults with
arthritis, CAM use was associated with poor perceived
general health (10,11), sleep disruption (12), or severe
pain (35). In one study, use of three or more types of CAM
was associated with longer disease duration (35). In the
present study, however, shorter duration of arthritis
among respondents with rheumatoid arthritis was asso-
ciated with current CAM use, and arthritis symptoms
were not significantly associated with CAM use.
Although similar percentages of Hispanic and non-
Hispanic white respondents with osteoarthritis used any
type of CAM, use of specific CAM therapies may vary by
Hispanic ethnicity. Exploration of this issue is beyond
the scope of the present overview.
An important finding of this study is that patterns of
CAM use did not necessarily correspond to CAM therapies
with evidence of effectiveness for particular types of arthri-
tis. Most striking is the high percentage of patients in each
diagnostic group with past and current use of glucosamine
and chondroitin. Rigorous scientific studies have shown
consistent moderate short-term benefits and safety of glu-
cosamine and chondroitin for osteoarthritis of the knee,
but there is no evidence for their effectiveness in rheuma-
toid arthritis or fibromyalgia (21,36,37). We checked for
concurrent osteoarthritis as a possible explanation of use
by those with rheumatoid arthritis and fibromyalgia, but
we found that none of the participants with rheumatoid
arthritis and only half of those with fibromyalgia using
glucosamine and chondroitin had osteoarthritis. Another
example is the low use of fish oil and GLA-containing sup-
plements among patients with rheumatoid arthritis, even
though they have been shown to reduce pain and improve
function in those who have rheumatoid arthritis (21,38).
Relying on friends, family members, and magazines for
information about CAM may have affected participants’
access to credible information specific to arthritis type.
High use of mind-body therapies was found in the present
study within each diagnostic group, especially among
those with fibromyalgia. The few efficacy studies of mind-
body therapies among patients with fibromyalgia have
had equivocal findings, but results are promising for
patients with osteoarthritis and rheumatoid arthritis (39). 
This study has several limitations. Sample sizes were
small for those with rheumatoid arthritis (n = 95) 
and fibromyalgia (n = 95), although the numbers of
osteoarthritis participants (n = 422) and total participants
(n = 612) were larger than in previous studies with clinic
samples. Results are not generalizable beyond the partic-
ular clinic population for several reasons: the response
rate was low; men, Hispanics, and those with rheumatoid
arthritis were oversampled; the SUDAAN weighted analy-
sis method provided estimates only within the particular
clinic population in the study and not a larger population;
the low-income, central New Mexican, university-affiliated
clinic population is unlikely to be representative of other
clinic populations in other locations; and New Mexican
Hispanics who self-identify as Spanish Americans may not
be representative of diverse Hispanic populations living
elsewhere. We used the SUDAAN weighted analysis
method to address oversampling certain groups, but this
method is intended for use with larger samples (34). Use of
CAM ever to manage longstanding arthritis is prone to
6 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2004/oct/03_0036.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.recall bias, and so we defined current use as use at the
time of the interview. There is still the limitation of asking
about CAM use at only one point in time. Definitions of
CAM are increasingly blurred as some therapies such as
vitamins have become part of conventional clinical prac-
tice and others such as capsaicin cream are now recom-
mended by the American College of Rheumatology
because of evidence of efficacy (3).
Efforts are needed to investigate how best to translate
and disseminate CAM efficacy research findings so people
will know which CAM therapies may benefit their type of
arthritis. Additional research is needed on efficacy and
safety of CAM therapies used by arthritis patients,
including research on potential negative interactions
between CAM therapies and conventional treatments
such as medications.
In conclusion, this study found that CAM use was high,
potentially costly, and not always communicated to the
treating physician among the osteoarthritis, rheumatoid
arthritis, and fibromyalgia patients treated by primary
care physicians in these clinics. Overall, 69% of the clinic
population currently used any type of CAM, and current
use was associated with being female, being under 55
years of age, and having a college education. Two thirds of
CAM users spent less than $50 per month on CAM, but
overall 15%, including 30% of the CAM users with
fibromyalgia, spent more than $100 per month on CAM.
Two thirds of CAM users in the study discussed CAM use
with their medical doctor; the main reason cited for not
disclosing CAM use was that the physician did not ask.
Physicians and other health care providers should be
aware of this high degree of CAM use among arthritis
patients and incorporate questions about such use into
their routine assessments and treatment planning.
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Hispanic (%)
Non-Hispanic white (%)
Female (%)
Male (%)
18-54 (%)
55-64 (%)
65-74 (%)
75-84 (%)
Mean
Median
Did not graduate from high school (%)
Rheumatoid
Arthritis
(n=95)
Diagnoses
Fibromyalgia
(n=95)
All
(n=612)
Pearson
Chi-square
P Value
Osteoarthritis
(n=422) Characteristics
47.8
52.2
66.6
33.4
21.5
34.9
27.9
15.7
62.6
61.8
28.9
49.2
50.8
84.6
15.4
41.2
31.1
22.9
4.8
56.0
57.8
21.0
30.2
69.8
85.6
14.4
43.2
39.2
16.9
0.8
54.8
55.2
7.7
44.6
55.4
71.4
28.6
26.9
35.4
25.5
12.2
60.6
59.9
24.3
.001
<.001
<.001
<.001
<.001
Ethnic Group
Sex
Age at interview (years)
Education
(Continued on next page)VOLUME 1: NO. 4
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Table 1. (continued)  Patient Characteristics by Diagnosis, Percentages Weighted by Inverse of Sampling Fraction, Survey on
Use of Complementary and Alternative Medicine (n = 612), New Mexico, 2001–2002
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High school graduate or GED (%)
Some college or technical school (%)
College graduate (%)
Unknown (%)
Less than $25,000 (%)
$25,000 to $50,000 (%)
$50,000 or more (%)
Unknown (%)
Never or <1 (%)
1-2 (%)
3-5 (%)
>5 (%)
Unknown (%)
0-5 (%)
6-14 (%)
15+ (%)
Unknown (%)
Mean 
Median
Low (0-4) (%)
Moderate (5-7) (%)
High (8-10) (%)
Unknown (%)
Mean 
Median
Rheumatoid
Arthritis
(n=95)
Diagnoses
Fibromyalgia
(n=95)
All
(n=612)
Pearson
Chi-square
P Value
Osteoarthritis
(n=422) Characteristics
19.5
21.9
29.5
0.2
64.4
18.2
12.8
4.6
26.6
24.9
30.8
16.0
1.6
34.0
33.1
32.8
0.2
12.6
9.1
38.1
38.9
21.6
1.3
5.3
5.0
26.6
27.1
25.3
0.0
66.2
15.0
13.9
4.9
10.5
30.2
32.9
26.4
0.0
21.0
41.7
37.2
0.0
15.3
11.8
41.2
33.8
25.0
0.0
5.3
5.0
22.0
39.8
30.5
0.0
66.9
16.8
14.0
2.3
14.3
17.4
30.0
38.3
0.0
32.4
36.8
30.3
0.6
12.0
8.2
23.2
36.1
40.7
0.0
6.6
6.3
20.5
25.7
29.4
0.1
65.0
17.7
13.1
4.2
23.2
23.9
30.8
20.9
1.2
32,8
34.4
32.6
0.2
12.6
9.1
35.5
38.0
25.5
1.0
5.6
5.2
<.001
.95
<.001
.07
.12
.004
<.001
Annual household income
Frequency of visits to medical doctor for arthritis (times per year)
Disease duration (years)
Pain in last week (0-10 visual scale)Table 2.  Weighted Estimates of Ever and Current Use of Complementary and Alternative Medicine Type, by Diagnosis, Survey
Results (n = 612), New Mexico, 2001–2002
VOLUME 1: NO. 4
OCTOBER 2004
www.cdc.gov/pcd/issues/2004/oct/03_0036.htm • Centers for Disease Control and Prevention 11
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.
Ever 
Current 
Ever 
Current 
Ever 
Current 
Ever 
Current 
Ever 
Current 
Ever 
Current 
Ever 
Current 
Ever 
Current 
Ever 
Current 
Ever 
Current 
Ever 
Current 
Ever 
Current
Rheumatoid
Arthritis
(n=95)
%
Diagnoses
Fibromyalgia
(n=95)
%
All
(n=612)
%
Pearson
Chi-square
P Value
Osteoarthritis
(n=422)
% Types of CAM
89.4
66.7
55.4
34.1
16.8
12.1
23.5
10.1
46.2
23.1
28.2
8.3
27.9
23.7
18.3
7.6
15.1
8.4
32.2
7.6
10.1
6.4
3.3
0.9
86.4
70.7
59.8
26.6
28.8
20.8
30.2
15.6
48.3
15.6
43.9
10.2
42.5
31.1
28.1
13.2
14.8
5.8
45.0
13.7
27.4
17.4
7.1
0.0
94.8
78.3
72.8
36.5
42.7
32.9
50.8
26.7
64.9
36.5
39.3
12.0
59.4
48.9
55.0
34.3
32.6
20.7
64.6
32.2
29.4
21.8
9.3
3.6
90.2
69.2
59.0
34.1
22.6
16.6
29.1
13.6
49.9
25.1
31.3
9.2
34.8
29.0
25.9
13.0
18.4
10.6
39.2
12.7
14.9
10.1
4.8
1.3
.08
.06
.007
.21
<.001
<.001
<.001
.002
.005
.004
.006
.56
<.001
<.001
<.001
<.001
.005
.01
<.001
<.001
<.001
<.001
.10
.06
Any type of CAM
Nutritional supplements
Vitamins and minerals
Herbs taken orally
Topical herbal rubs
Items worn
Mind-body therapies
CAM therapists
Dietary approaches
Homeopathy
Energy therapiesa
Movement therapiesb
aTherapies such as acupressure, reflexology, reiki, therapeutic touch, and aromatherapy.
bPrimarily yoga, tai chi, and Feldenkrais.VOLUME 1: NO. 4
OCTOBER 2004
Table 3.  Weighted Estimates of the Percentages of Osteoarthritis, Rheumatoid Arthritis, and Fibromyalgia Patients Using
Complementary and Alternative Medicine at Time of Interview, Survey Results (n = 612), New Mexico, 2001–2002a
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Nutritional supplements
Vitamins and minerals
Herbs taken orally 
Homeopathy
Topical rubs
Glucosamine
Chondroitin
MSM
Flaxseed oil
Vinegar
Fish oil
Cod liver oil
GLA (Gamma
linolenic acid) (e.g.,
borage oil, black
currant oil, evening
primrose oil)
Magnesium
Vitamin E
Vitamin C
Vitamin B12
Niacin 
Zinc
Vitamin B Complex
Selenium
Garlic
Ginger
Valerian root
Aloe vera 
St. John’s wort
Turmeric
Arnica (oral)
Tiger balm
Arnica cream
Chamomile oil
Capsaicin cream
Sesame oil
Horse liniment
Traumeel ointment
Rosemary oil
Aloe vera cream
Rheumatoid
Arthritis
(n=95)
%
Diagnoses
Fibromyalgia
(n=95)
%
All
(n=612)
%
Pearson
Chi-square
P Value
Osteoarthritis
(n=422)
%
Type of Complementary and
Alternative Medicine
25.2
17.9
4.6
1.9
4.5
3.0
1.9
0.6
3.1
4.3
4.1
3.4
0.2
1.3
0.9
0.3
4.4
1.4
1.1
1.0
0.0
0.5
0.3
5.1
2.2
1.0
4.6
0.3
1.3
1.2
0.5
1.1
15.8
7.5
4.2
5.3
5.1
6.1
0.9
1.3
4.2
8.6
10.0
4.7
0.0
3.1
2.4
0.0
6.9
4.6
2.9
3.4
1.7
1.7
0.0
4.2
1.7
0.0
0.9
0.0
3.9
1.7
1.2
0.0
20.7
10.6
9.9
9.9
3.4
6.4
3.6
3.5
14.1
11.1
9.7
5.0
5.5
3.9
4.0
3.7
8.2
4.0
4.6
3.1
3.3
3.4
3.6
10.8
5.1
4.9
3.6
3.6
2.8
4.6
3.0
3.1
23.7
15.8
5.6
3.6
4.3
3.9
2.2
1.2
5.3
5.9
5.6
3.8
1.2
1.9
1.2
0.9
5.3
2.1
1.9
1.6
0.7
1.1
0.9
6.1
2.7
1.6
4.1
0.9
1.8
1.8
1.0
1.4
.09
.006
.26
.02
.83
.27
.35
.31
.02
.08
.06
.74
.06
.32
.23
.15
.34
.16
.19
.29
.09
.24
.15
.19
.42
.02
.03
.09
.33
.33
.34
.02
(Continued on next page)VOLUME 1: NO. 4
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Table 3. (continued)  Weighted Estimates of the Percentages of Osteoarthritis, Rheumatoid Arthritis, and Fibromyalgia
Patients Using Complementary and Alternative Medicine at Time of Interview, Survey Results (n = 612), New Mexico,
2001–2002a
Items worn
Mind-body therapies
Energy therapies
Movement therapies
CAM therapists
Dietary approaches
Magnets
Copper jewelry
Relaxation techniques
Meditation
Breathing techniques
Music therapy
Visualization
Acupressure
Reflexology
Aromatherapy
Therapeutic touch
Self-massage
Electromagnetic
Reiki
Yoga
Tai chi
Feldenkrais
Massage therapists
Chiropractors
Acupuncturists
Myofascial therapists
Osteopathic doctor
“Arthritis diet”
Fasting or cleansing
diet
Hypoglycemic diet
Vegetarian diet
Rheumatoid
Arthritis
(n=95)
%
Diagnoses
Fibromyalgia
(n=95)
%
All
(n=612)
%
Pearson
Chi-square
P Value
Osteoarthritis
(n=422)
%
Type of Complementary and
Alternative Medicine
4.6
4.2
10.0
10.1
8.4
6.2
6.8
2.4
0.7
1.1
1.1
0.2
1.5
0.4
4.9
2.6
0.5
4.8
1.5
2.1
0.2
0.0
1.4
0.2
0.4
1.2
7.6
3.8
16.3
11.1
9.8
8.8
7.4
2.9
2.0
3.2
2.7
3.2
2.0
0.9
4.9
0.9
0.0
4.4
1.7
2.9
0.0
0.9
8.5
4.0
0.0
1.7
9.6
2.8
28.9
27.6
36.7
22.8
19.6
19.5
9.8
7.4
4.8
0.9
4.1
3.5
13.2
6.3
5.1
17.1
10.3
5.5
3.2
3.2
4.4
7.3
5.0
3.6
5.7
3.9
14.0
13.5
13.8
9.5
9.2
5.7
2.5
2.4
1.9
0.5
2.0
1.1
6.5
3.2
1.3
7.1
3.1
2.8
0.8
0.7
2.4
1.8
1.2
1.7
.22
.79
.001
.004
<.001
.002
.02
.001
.02
.05
.16
.19
.54
.32
.09
.09
.04
.01
.05
.46
.14
.13
.02
.006
.04
.45
aTable includes complementary and alternative medicine (CAM) items used by 3% or more of patients in at least one diagnostic group. See Appendix for
complete list of CAM items included in the survey.
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Table 4.  Weighted Estimates of Current Use of Any Type of Complementary and Alternative Medicine, by Patient
Characteristics and Diagnostic Group, Survey Results (n = 612), New Mexico, 2001–2002
Ethnic group
Sex
Age at interview
(years)
Education
Annual household
income
Frequency of visits to
medical doctor for
arthritis (times per
year)
Duration of disease
(years)
Hispanic 
Non-Hispanic White
(Pearson chi-square P
value)
Female
Male 
(Pearson chi-square P
value)
18-54
55-64
65-84
(Pearson chi-square P
value)
Did not graduate from
high school 
High school graduate
or GED 
Some college or tech-
nical school
College graduate 
(Pearson chi-square P
value)
Less than $25,000 
$25,000 to $50,000
$50,000 or more 
(Pearson chi-square P
value)
Never or < 1 
1-2 
3-5 
>5
(Pearson chi-square P
value)
0-5
6-14
Rheumatoid
Arthritis
(n=95)
%
Diagnoses
Fibromyalgia
(n=95)
%
All
Participants
(n=612)
%
Test of
Interaction
P Value
Osteoarthritis
(n=422)
% Patient Characteristics
65.5
67.8
(0.62)
69.3
61.5
(0.11)
71.9
68.3
62.8
(0.30)
60.7
65.7
66.6
73.1
(0.24)
67.0
62.2
72.0
(0.54)
60.4
69.0
69.1
67.1
(0.52)
60.3
67.4
54.8
86.0
(0.001)
71.8
64.0
(0.60)
77.9
70.1
60.6
(0.37)
57.0
59.8
72.7
91.3
(0.02)
66.9
80.4
82.2
(0.36)
82.9
84.6
59.1
64.3
(0.08)
91.5
60.3
70.9
81.5
(0.27) 
79.6
70.7
(0.55)
84.8
78.1
62.9
(0.26)
49.0
69.1
81.2
88.7
(0.14)
75.9
82.1
90.0
(0.45)
51.3
81.3
86.1
81.0
(0.25)
74.6
79.8
65.4
72.2
(0.08)
71.9
62.4
(0.03) 
76.4
70.4
62.7
(0.02)
59.8
65.9
71.3
77.3
(0.009)
68.7
66.8
76.3
(0.34)
60.1
72.0
71.4
71.7
(0.14)
64.3
69.3
NAa
NA
.03
NA
NA
.98 
NA
NA
NA
.84
NA
NA
NA
NA
.44
NA
NA
NA
.68
NA
NA
NA
NA
.15
NA
NA
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Table 4. (continued)  Weighted Estimates of Current Use of Any Type of Complementary and Alternative Medicine, by Patient
Characteristics and Diagnostic Group, Survey Results (n = 612), New Mexico, 2001–2002
Nutritional supplements: glucosamine, chondroitin, MSM, SAMe,
shark cartilage, bovine cartilage, collagen, cod liver oil, fish oil,
flaxseed oil, GLA-containing supplements (borage oil, black currant
oil, evening primrose oil), vinegar, bromelain, quercetin, noni juice,
pregnenolone, DLPA, glutathione, malic acid. Vitamins & miner-
als: Multiple vitamina, calciuma, vitamin Da, vitamin C, vitamin E,
beta carotene, niacin, vitamin B5, vitamin B12, folic acida, mag-
nesium, selenium, boron, copper, zinc. Oral herbs: aloe vera,
angelica root, black cohosh, boswellia (guggul), burdock root &
seed, cactus, calendula, cat’s claw, cayenne, celery seed, coix,
corydalis, devil’s claw, eucalyptus, fennel, feverfew, foti (Hou Shu
Wu), garlic, gentian, ginger, kava kava, thundergod vine, licorice,
oregano, St. John’s wort, stinging nettle, turmeric, valerian root,
white willow bark, wild yam, yucca. Topical oils, rubs and oint-
ments: arnica cream, calendula, capsaicin creams, chamomile oil,
clay, coriander cream, DMSO, horse liniment, linseed oil, MSM
creams, pine tree sap, rosemary oil, sesame oil, tiger balm,
traumeel or traumed ointment, volcanico. Items worn: acupres-
sure beads or seeds, copper jewelry, herbal plasters, infrared
wraps, magnets, Q-ray ionically charged bracelet. Mind-body ther-
apies: meditation, visualization, special breathing techniques,
relaxation techniques, music therapy, draw upon religious or spiri-
tual beliefsa, praya, attend religious services regularlya. Energy
therapies: acupressure, aromatherapy, biofeedback, cranio-sacral
therapy, hypnotism, polarity, reflexology, reiki, therapeutic touch.
Movement therapies: yoga, tai chi, qigong, pilates, Feldenkrais
method (“Awareness Through Movement”), Alexander movement
techniques, Trager approach (“Mentastics”). CAM therapists: doc-
tor of oriental medicine or acupuncturist, ayurvedic doctor, chiro-
practic doctor, curandero/curandera, herbalist, hypnotist, iridologist,
massage therapist, myofascial therapist, naturopathic doctor,
osteopathic doctor, religious leader, spiritual healer. Dietary
approaches: “arthritis diet” with fish, fresh fruits, and vegetables
except potatoes, tomatoes, eggplant, peppers; ayurvedic diet; fast-
ing and cleansing diets; hypoglycemic diet; vegetarian diet.
aItem excluded from analyses.
Pain in last week
15+
(Pearson chi-square P
value)
Low 
Moderate
High
(Pearson chi-square P
value)
Rheumatoid
Arthritis
(n=95)
%
Diagnoses
Fibromyalgia
(n=95)
%
All
Participants
(n=612)
%
Test of
Interaction
P Value
Osteoarthritis
(n=422)
% Patient Characteristics
72.9
(0.09)
64.3
66.5
72.9
(0.36)
70.6
(0.01)
77.8
70.9
58.5
(0.33)
80.1
(0.85)
85.0
81.3
71.9
(0.46)
74.0
(0.13)
67.9
69.4
71.6
(0.77)
NA
.11
NA
NA
NA
.23
aNA indicates not applicable.
Appendix
Complementary and Alternative Medicine Items Included in Survey of Hispanic and Non-Hispanic White Women and Men
Aged 18–84 (n = 612), New Mexico, 2001–2002
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